MX2016010778A - Metodos para la produccion de biopolimeros con peso molecular promedio definido. - Google Patents
Metodos para la produccion de biopolimeros con peso molecular promedio definido.Info
- Publication number
- MX2016010778A MX2016010778A MX2016010778A MX2016010778A MX2016010778A MX 2016010778 A MX2016010778 A MX 2016010778A MX 2016010778 A MX2016010778 A MX 2016010778A MX 2016010778 A MX2016010778 A MX 2016010778A MX 2016010778 A MX2016010778 A MX 2016010778A
- Authority
- MX
- Mexico
- Prior art keywords
- molecular weight
- production
- biopolymer
- average molecular
- biopolymers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B3/00—Preparation of cellulose esters of organic acids
- C08B3/22—Post-esterification treatments, including purification
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0018—Pullulan, i.e. (alpha-1,4)(alpha-1,6)-D-glucan; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0045—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0087—Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
- C08H1/06—Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polyethers (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Polyesters Or Polycarbonates (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a un método para la producción de un biopolímero, en donde el biopolímero tiene un peso molecular promedio definido, el método comprende la liofilización de una composición que comprende al biopolímero con un alto peso molecular nativo, opcionalmente la purificación y/o aislamiento del biopolímero; en donde la temperatura durante el proceso de sublimación es seleccionada para facilitar una degradación controlada y definida de dicho biopolímero.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14155840.3A EP2910255A1 (en) | 2014-02-19 | 2014-02-19 | Methods for the production of biopolymers with defined average molecular weight |
PCT/EP2015/052540 WO2015124445A1 (en) | 2014-02-19 | 2015-02-06 | Methods for the production of biopolymers with defined average molecular weight |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016010778A true MX2016010778A (es) | 2017-04-06 |
Family
ID=50115746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016010778A MX2016010778A (es) | 2014-02-19 | 2015-02-06 | Metodos para la produccion de biopolimeros con peso molecular promedio definido. |
Country Status (12)
Country | Link |
---|---|
US (1) | US11091566B2 (es) |
EP (2) | EP2910255A1 (es) |
JP (3) | JP2017508040A (es) |
KR (1) | KR20160147254A (es) |
CN (2) | CN106456790A (es) |
AU (1) | AU2015221066B2 (es) |
CA (1) | CA2937052C (es) |
ES (1) | ES2939011T3 (es) |
MX (1) | MX2016010778A (es) |
RU (1) | RU2700420C2 (es) |
SG (2) | SG10202102316RA (es) |
WO (1) | WO2015124445A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3095345B1 (fr) * | 2019-04-29 | 2021-11-12 | Strand Cosmetics Europe | Composition cosmetique comprenant une matrice polymerique |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1212892B (it) * | 1983-10-11 | 1989-11-30 | Della Valle Francesco | Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica |
IT1229075B (it) * | 1985-04-05 | 1991-07-17 | Fidia Farmaceutici | Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico |
EP0138572B1 (en) * | 1983-10-11 | 1990-07-25 | FIDIA S.p.A. | Hyaluronic acid fractions having pharmaceutical activity, methods for preparation thereof, and pharmaceutical compositions containing the same |
SE9400036D0 (sv) * | 1994-01-10 | 1994-01-10 | Pharmacia Ab | Low modecular weight hyaluronic acid |
FR2776520B1 (fr) * | 1998-03-25 | 2000-05-05 | Sod Conseils Rech Applic | Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation |
WO2002045767A1 (fr) * | 2000-12-07 | 2002-06-13 | Japan Tissue Engineering Co.,Ltd | Substrat de regeneration de tissus, materiel de transplantation, et procedes de production de ces elements |
US20040002451A1 (en) * | 2002-06-20 | 2004-01-01 | Bruce Kerwin | Compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing |
JP2006182750A (ja) * | 2004-12-27 | 2006-07-13 | Bio Meito:Kk | 凍結乾燥化粧品およびその製造方法 |
JP4576583B2 (ja) | 2005-03-22 | 2010-11-10 | キユーピー株式会社 | ヒアルロン酸またはその塩、およびその製造方法、ならびにこれを含有する化粧料および食品組成物 |
US20080038780A1 (en) | 2006-02-15 | 2008-02-14 | Novozymes Biopolymer A/S | Production of low molecular weight hyaluronic acid |
CN101415731B (zh) | 2006-02-24 | 2011-11-02 | 丘比株式会社 | 新型低分子透明质酸和/或其盐以及使用其的化妆品、医药组合物和食品组合物 |
CA2741422A1 (en) * | 2008-10-22 | 2010-04-29 | De Staat Der Nederlanden, Vert. Door De Minister Van Vws | Preservation mixture and use thereof |
JP5724108B2 (ja) * | 2009-04-22 | 2015-05-27 | メドスキン ソリューションズ ドクター ズベラック アーゲーMedSkin Solutions Dr.Suwelack AG | 凍結乾燥組成物 |
JP2011057607A (ja) | 2009-09-09 | 2011-03-24 | Toshitsu Kagaku Kenkyusho:Kk | ヒアルロン酸およびヒアルロン酸オリゴを含有する組成物 |
KR101132114B1 (ko) | 2009-09-15 | 2012-04-05 | 일동제약주식회사 | 히알루론산의 분자량을 조절하는 방법 |
CN101889603A (zh) * | 2010-07-23 | 2010-11-24 | 连云港口福食品有限公司 | 一种冻干牛蒡的生产工艺 |
US8722854B2 (en) * | 2010-12-23 | 2014-05-13 | Medskin Solutions Dr. Suwelack Ag | Degradation-stabilised, biocompatible collagen matrices |
JP5683410B2 (ja) | 2011-08-18 | 2015-03-11 | キユーピー株式会社 | 化粧料 |
JP5827079B2 (ja) | 2011-09-02 | 2015-12-02 | ポーラ化成工業株式会社 | 粉体含有皮膚外用剤 |
JP6077424B2 (ja) * | 2013-09-10 | 2017-02-08 | 大日精化工業株式会社 | 水不溶性成形体の製造方法及び水不溶性成形体 |
-
2014
- 2014-02-19 EP EP14155840.3A patent/EP2910255A1/en not_active Withdrawn
-
2015
- 2015-02-06 WO PCT/EP2015/052540 patent/WO2015124445A1/en active Application Filing
- 2015-02-06 EP EP15702814.3A patent/EP3107579B1/en active Active
- 2015-02-06 JP JP2016551786A patent/JP2017508040A/ja active Pending
- 2015-02-06 RU RU2016129070A patent/RU2700420C2/ru not_active IP Right Cessation
- 2015-02-06 US US15/118,269 patent/US11091566B2/en active Active
- 2015-02-06 SG SG10202102316RA patent/SG10202102316RA/en unknown
- 2015-02-06 CN CN201580009027.XA patent/CN106456790A/zh active Pending
- 2015-02-06 CA CA2937052A patent/CA2937052C/en active Active
- 2015-02-06 ES ES15702814T patent/ES2939011T3/es active Active
- 2015-02-06 KR KR1020167025550A patent/KR20160147254A/ko not_active Application Discontinuation
- 2015-02-06 CN CN202011474339.7A patent/CN112694545A/zh active Pending
- 2015-02-06 MX MX2016010778A patent/MX2016010778A/es unknown
- 2015-02-06 AU AU2015221066A patent/AU2015221066B2/en not_active Ceased
- 2015-02-06 SG SG11201606260XA patent/SG11201606260XA/en unknown
-
2017
- 2017-12-08 JP JP2017236317A patent/JP2018076340A/ja active Pending
-
2020
- 2020-07-28 JP JP2020127062A patent/JP7250351B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
RU2700420C2 (ru) | 2019-09-17 |
KR20160147254A (ko) | 2016-12-22 |
JP2020183544A (ja) | 2020-11-12 |
RU2016129070A (ru) | 2018-03-22 |
CA2937052C (en) | 2019-03-19 |
RU2016129070A3 (es) | 2018-03-22 |
CN106456790A (zh) | 2017-02-22 |
WO2015124445A1 (en) | 2015-08-27 |
EP3107579B1 (en) | 2022-11-30 |
ES2939011T3 (es) | 2023-04-18 |
EP2910255A1 (en) | 2015-08-26 |
JP7250351B2 (ja) | 2023-04-03 |
JP2018076340A (ja) | 2018-05-17 |
US20160355611A1 (en) | 2016-12-08 |
SG11201606260XA (en) | 2016-09-29 |
AU2015221066B2 (en) | 2018-07-19 |
JP2017508040A (ja) | 2017-03-23 |
SG10202102316RA (en) | 2021-04-29 |
CA2937052A1 (en) | 2015-08-27 |
CN112694545A (zh) | 2021-04-23 |
US11091566B2 (en) | 2021-08-17 |
AU2015221066A1 (en) | 2016-08-11 |
EP3107579A1 (en) | 2016-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201707639B (en) | Processes for producing 2,5-furandicarboxylic acid and derivatives thereof and polymers made therefrom | |
EP3225657A4 (en) | Rubber composition, process for producing same, and tire | |
EP3221391A4 (en) | Swellable compositions, articles formed therefrom, and methods of manufacture thereof | |
MX2018002206A (es) | Composiciones no toxicas de agente para plantas y sus metodos y usos. | |
MY185267A (en) | Composition comprising a multistage polymer, it method of preparation and its use | |
SG10201807693YA (en) | Methods for recombinant production of saffron compounds | |
EP3138874A4 (en) | Rubber composition for tire, production method for rubber composition for tire, and tire | |
HUE050766T2 (hu) | Kitin, hidrolizátum és a keresett termék(ek) elõállítási eljárása rovarokból, enzimes hidrolízissel | |
MX2021014663A (es) | Il-23a y tnf-alfa orientados y compuesto y sus usos. | |
MY172601A (en) | Improved process for preparing fermented soybean meal | |
EP3510868A4 (en) | PLANT ACTIVATOR, AND MANUFACTURING METHOD THEREOF | |
ZA201803510B (en) | Process for the production of 2,5-furandicarboxylic acid (fdca) | |
MX2018015298A (es) | Metodo para estabilizar proteinas. | |
MX2016017127A (es) | Proceso para la preparacion de acidos 4-alcoxi-3-hidroxipicolinico s. | |
EP3197469A4 (en) | Stevia composition, production method and uses | |
MX2017003301A (es) | Producto refractario, relleno para fabricar el producto, procedimiento para fabricar el producto y uso del producto refractario. | |
EP3237559A4 (en) | Polymer mixture, multilayer article containing same, and process of preparing multilayer article | |
IN2014MU00455A (es) | ||
EP3190138A4 (en) | Hyperbranched polymer, process for producing same, and composition | |
EP3131341A4 (en) | Method and system for updating closed subscriber group identity state, and evolved node b | |
WO2016068656A3 (ko) | 사이코스 에퍼머화 효소의 발현 시스템 및 이를 이용한 사이코스의 생산 | |
MX2016015555A (es) | Sustrato metanogeno para la produccion de biogas. | |
EP3722350A4 (en) | METHOD FOR PRODUCING AN ORGANIC FILLER AS AN ADDITIVE TO A PLASTIC AND ORGANIC FILLER MANUFACTURED AS AN ADDITIVE TO A PLASTIC | |
EP3141573A4 (en) | Curable polysilsesquioxane compound, production method thereof, curable composition, cured product and use method of curable composition, etc. | |
EP3394174A4 (en) | COMPOSITION, PROCESS FOR PREPARING A COMPOSITION AND OBJECT |